Follow
Mitchell Isaac Parker
Mitchell Isaac Parker
MD/PhD Candidate, Drexel University College of Medicine
Verified email at drexel.edu
Title
Cited by
Cited by
Year
Association of TP53 and CDKN2A Mutation Profile with Tumor Mutation Burden in Head and Neck Cancer
AY Deneka, Y Baca, IG Serebriiskii, E Nicolas, MI Parker, TT Nguyen, ...
Clinical Cancer Research 28 (9), 1925-1937, 2022
372022
Proliferative signaling by ERBB proteins and RAF/MEK/ERK effectors in polycystic kidney disease
MI Parker, AS Nikonova, D Sun, EA Golemis
Cellular signalling 67, 109497, 2020
282020
Comprehensive characterization of PTEN mutational profile in a series of 34,129 colorectal cancers
IG Serebriiskii, V Pavlov, R Tricarico, G Andrianov, E Nicolas, MI Parker, ...
Nature Communications 13 (1), 1618, 2022
262022
Micro RNA s downregulated following immune activation of rat testis
MI Parker, MA Palladino
American Journal of Reproductive Immunology 77 (6), e12673, 2017
262017
Delineating the RAS conformational landscape
MI Parker, JE Meyer, EA Golemis, RL Dunbrack Jr
Cancer research 82 (13), 2485-2498, 2022
132022
Stmol: A component for building interactive molecular visualizations within streamlit web-applications
JM Nápoles-Duarte, A Biswas, MI Parker, JP Palomares-Baez, ...
Frontiers in Molecular Biosciences 9, 990846, 2022
122022
Structure of TFIIK for phosphorylation of CTD of RNA polymerase II
T van Eeuwen, T Li, HJ Kim, JJ Gorbea Colón, MI Parker, RL Dunbrack, ...
Science advances 7 (15), eabd4420, 2021
112021
Correlation of tumor mutational burden (TMB) with CDKN2A and TP53 mutation in HPV-negative head and neck squamous cell carcinoma (HNSCC).
B Burtness, A Deneka, Y Baca, I Serebriiskii, MI Parker, E Nicolas, JW Lee, ...
Journal of Clinical Oncology 38 (15_suppl), 6552-6552, 2020
92020
Multiplexed screens identify RAS paralogues HRAS and NRAS as suppressors of KRAS-driven lung cancer growth
R Tang, EG Shuldiner, M Kelly, CW Murray, JD Hebert, L Andrejka, ...
Nature cell biology 25 (1), 159-169, 2023
82023
A penultimate classification of canonical antibody CDR conformations
S Kelow, B Faezov, Q Xu, M Parker, J Adolf-Bryfogle, RL Dunbrack Jr
bioRxiv, 2022.10. 12.511988, 2022
52022
H. Pylori in a gastric schwannoma: a case report
DS Lavy, ET Paulin, MI Parker, B Zhang, GS Parker, MR Schwartz
Annals of Translational Medicine 4 (7), 2016
52016
The impact of radiation on an unusual case of omental epithelioid angiosarcoma
S Narayanan, M Parker, J Shayo, M Zheng, T Matulewicz, G Parker
Case Reports in Surgery 2015, 2015
42015
Building bioinformatics web applications with Streamlit
C Nantasenamat, A Biswas, JM Nápoles-Duarte, MI Parker, ...
Cheminformatics, QSAR and Machine Learning Applications for Novel Drug …, 2023
32023
Multiplexed identification of RAS paralog imbalance as a driver of lung cancer growth
R Tang, EG Shuldiner, M Kelly, CW Murray, JD Hebert, L Andrejka, ...
bioRxiv, 2021.07. 08.451571, 2021
22021
Defining an expanded RAS conformational landscape based on over 700 experimentally determined structures of KRAS, NRAS, and HRAS
MI Parker, JE Meyer, EA Golemis, RL Dunbrack Jr
bioRxiv, 2022.02. 02.478568, 2022
12022
E protein control of NKgammadeltaT cell development through both generation and function of the stereotypic Vgamma1Vdelta6. 3 TCR
DL Wiest, A Mihai, SY Lee, S Shinton, MI Parker, AV Contreras, B Zhang, ...
bioRxiv, 2024.01. 04.574274, 2024
2024
A Comprehensive Structural Classification of RAS Conformations
MI Parker
Drexel University, 2022
2022
An expanded classification of active, inactive, and druggable RAS conformations
MI Parker, JE Meyer, EA Golemis, RL Dunbrack
bioRxiv, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–18